PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ASM vs. SRPT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ASM and SRPT is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ASM vs. SRPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%500.00%600.00%AugustSeptemberOctoberNovemberDecember2025
-18.52%
487.06%
ASM
SRPT

Key characteristics

Sharpe Ratio

ASM:

2.00

SRPT:

0.02

Sortino Ratio

ASM:

2.79

SRPT:

0.45

Omega Ratio

ASM:

1.32

SRPT:

1.05

Calmar Ratio

ASM:

1.57

SRPT:

0.02

Martin Ratio

ASM:

8.54

SRPT:

0.05

Ulcer Index

ASM:

16.33%

SRPT:

17.63%

Daily Std Dev

ASM:

69.93%

SRPT:

48.03%

Max Drawdown

ASM:

-94.10%

SRPT:

-98.17%

Current Drawdown

ASM:

-71.58%

SRPT:

-33.98%

Fundamentals

Market Cap

ASM:

$154.58M

SRPT:

$11.27B

EPS

ASM:

$0.02

SRPT:

$1.56

PE Ratio

ASM:

55.00

SRPT:

75.64

PEG Ratio

ASM:

0.00

SRPT:

159.25

Total Revenue (TTM)

ASM:

$42.02M

SRPT:

$1.24B

Gross Profit (TTM)

ASM:

$12.93M

SRPT:

$1.05B

EBITDA (TTM)

ASM:

$9.10M

SRPT:

$119.07M

Returns By Period

In the year-to-date period, ASM achieves a 24.86% return, which is significantly higher than SRPT's -2.95% return. Over the past 10 years, ASM has underperformed SRPT with an annualized return of -4.87%, while SRPT has yielded a comparatively higher 25.99% annualized return.


ASM

YTD

24.86%

1M

23.60%

6M

12.27%

1Y

139.13%

5Y*

15.97%

10Y*

-4.87%

SRPT

YTD

-2.95%

1M

-1.87%

6M

-18.96%

1Y

1.03%

5Y*

-1.60%

10Y*

25.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ASM vs. SRPT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASM
The Risk-Adjusted Performance Rank of ASM is 8989
Overall Rank
The Sharpe Ratio Rank of ASM is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of ASM is 9090
Sortino Ratio Rank
The Omega Ratio Rank of ASM is 8585
Omega Ratio Rank
The Calmar Ratio Rank of ASM is 8787
Calmar Ratio Rank
The Martin Ratio Rank of ASM is 8989
Martin Ratio Rank

SRPT
The Risk-Adjusted Performance Rank of SRPT is 4545
Overall Rank
The Sharpe Ratio Rank of SRPT is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of SRPT is 4545
Sortino Ratio Rank
The Omega Ratio Rank of SRPT is 4343
Omega Ratio Rank
The Calmar Ratio Rank of SRPT is 4646
Calmar Ratio Rank
The Martin Ratio Rank of SRPT is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ASM vs. SRPT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ASM, currently valued at 2.00, compared to the broader market-2.000.002.004.002.000.02
The chart of Sortino ratio for ASM, currently valued at 2.79, compared to the broader market-4.00-2.000.002.004.002.790.45
The chart of Omega ratio for ASM, currently valued at 1.32, compared to the broader market0.501.001.502.001.321.05
The chart of Calmar ratio for ASM, currently valued at 1.57, compared to the broader market0.002.004.006.001.570.02
The chart of Martin ratio for ASM, currently valued at 8.54, compared to the broader market-10.000.0010.0020.0030.008.540.05
ASM
SRPT

The current ASM Sharpe Ratio is 2.00, which is higher than the SRPT Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of ASM and SRPT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
2.00
0.02
ASM
SRPT

Dividends

ASM vs. SRPT - Dividend Comparison

Neither ASM nor SRPT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ASM vs. SRPT - Drawdown Comparison

The maximum ASM drawdown since its inception was -94.10%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for ASM and SRPT. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-71.58%
-33.98%
ASM
SRPT

Volatility

ASM vs. SRPT - Volatility Comparison

Avino Silver & Gold Mines Ltd. (ASM) has a higher volatility of 21.16% compared to Sarepta Therapeutics, Inc. (SRPT) at 9.01%. This indicates that ASM's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
21.16%
9.01%
ASM
SRPT

Financials

ASM vs. SRPT - Financials Comparison

This section allows you to compare key financial metrics between Avino Silver & Gold Mines Ltd. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab